Send mail to Author

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___      _  __   __   __    _____     ______  
 /_____//   / _ \\   | |/ //  \ \\/ //  / ____||  /_   _// 
 `____ `   | / \ ||  | ' //    \ ` //  / //---`'   -| ||-  
 /___//    | \_/ ||  | . \\     | ||   \ \\___     _| ||_  
 `__ `      \___//   |_|\_\\    |_||    \_____||  /_____// 
 /_//       `---`    `-` --`    `-`'     `----`   `-----`  
 `-`
 


Back to frontdoor view

OPUS4 Logo